← Back to all trials
Enrolling By Invitation
NCT07463430
Suzetrigine for Non-Mastectomy Breast Surgery
Conditions: Pain, Acute Postoperative, Breast Disease
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 120
Sponsor: University of California, San Diego
Location: University of California San Diego San Diego California
Summary
This is a single-center clinical study to investigate the efficacy of a Food and Drug Administration-approved analgesic, suzetrigine, to treat pain following non-mastectomy breast surgery in concert with a single-injection paravertebral nerve block.
Eligibility Criteria
Inclusion Criteria:
1. Adult participants of at least 18 years of age
2. Undergoing uni-or bilateral surgical procedures of the breast(s) anticipated to result in at least moderate pain (NRS \> 3)
3. Planned single-injection peripheral nerve block(s)
Exclusion Criteria:
1. Chronic opioid or tramadol use (daily within prior 2 weeks and duration \> 4 weeks)
2. Neurological deficit of the surgical area
3. History of opioid misuse or dependence
4. Renal impairment with a GFR\
Source: ClinicalTrials.gov (NCT07463430). StuddyBuddy aggregates publicly available trial information.
